Tate & Lyle announces plans for new food ingredients

| Filed in:
Tate & Lyle PLC today announced plans to develop and manufacture a new range of products based on its world-leading fermentation capability. An efficient proprietary process, newly developed by Tate & Lyle’s Research & Development team, will be commercialised to produce Xanthan Gum and other related bio products from carbohydrate feedstock. Xanthan, which currently has a global market that totals more than $250 million, is used extensively as a food ingredient, offering thickening and gelling properties. It also has a number of important industrial applications in coatings, pharmaceuticals, adhesives, cosmetics and oil well fluids. The phase-one plant will be added to existing facilities in Decatur, Illinois. First product from the plant is expected to be commercially available within approximately 18 months. It is anticipated that full-scale capacity will be added in subsequent phases, dependent on market conditions. "This move is in line with our strategy to grow Tate & Lyle’s valued added carbohydrate-based ingredients," Simon Gifford, Tate & Lyle Group Finance Director said. "We already supply the world’s major branded food companies with a range of high-quality ingredients. This development will widen our product base using our existing sales, technical and distribution teams as well as providing an important testing platform for fermentation developments coming out of our global Research and Development team."

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube